Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer

被引:11
作者
Nam, Su Youn [1 ]
Jeon, Seong Woo [1 ]
Lee, Hyun Seok [1 ]
Kwon, Yong Hwan [1 ]
Park, Haeyoon [1 ]
Choi, Jin Woo [1 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Med Ctr, Daegu, South Korea
关键词
Eradication; Helicobacter pylori; Long term follow-up; Pepsinogen; ACID-SUPPRESSIVE THERAPY; SERUM PEPSINOGEN; CELLULAR-LOCALIZATION; INFECTION; DIAGNOSIS; ATROPHY; RISK; IMMUNOFLUORESCENCE; CARCINOMA; HISTOLOGY;
D O I
10.1016/j.dld.2016.12.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although the pepsinogen I/II (PGI/II) ratio after Helicobacter pylori eradication is recovered at short-term follow-up, long-term follow-up studies of PGI/II are rare. Methods: A total of 773 patients with gastric cancer who underwent endoscopic resection and pepsinogen and H. pylori tests were enrolled. H. pylori was eradicated in these patients. Endoscopic and pepsinogen tests were performed every year. A low PGI/II ratio was defined as <= 3. Results: The PGI/II ratio was higher in non-infected patients (n = 275, 4.99) than infected patients (n = 498, 3.53). After H. pylori eradication, the PGI/II ratio increased to 5.81 and 5.63 after 1 and 2 years (each p < 0.05). The PGI/II ratio in the non-eradication group decreased to 3.94 and 2.75 after 1 and 2 years. The PGI/II ratio in the H. pylori eradication group became similar to that of the H. pylori-negative group at 3 (4.48 vs. 4.34), 4 (4.88 vs. 4.34), and 5 years (4.89 vs. 4.23). The adjusted odds ratios for a lower PG I/II ratio in the non-eradication group compared to the eradication group were 4.78 (95% CI 2.15-10.67) after 1 year and 8.13 (95% CI 2.56-25.83) after 2 years. Conclusions: After H. pylori eradication, the PGI/II ratio increased and was similar to that of H. pylori-negative controls for up to 5 years of follow-up. (C) 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:500 / 506
页数:7
相关论文
共 33 条
[31]   Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study [J].
Shikata, Kentaro ;
Ninomiya, Toshiharu ;
Yonemoto, Koji ;
Ikeda, Fumie ;
Hata, Jun ;
Doi, Yasufumi ;
Fukuhara, Masayo ;
Matsumoto, Takayuki ;
Iida, Mitsuo ;
Kitazono, Takanari ;
Kiyohara, Yutaka .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (06) :669-675
[32]   Comparison of serum IgA and IgG antibodies for detecting Helicobacter pylori infection [J].
Urita, Y ;
Hike, K ;
Torii, N ;
Kikuchi, Y ;
Kurakata, H ;
Kanda, E ;
Sasajima, M ;
Miki, K .
INTERNAL MEDICINE, 2004, 43 (07) :548-552
[33]   Effect of Helicobacter pylori Eradication on Metachronous Gastric Cancer after Endoscopic Resection of Gastric Tumors: A Meta-Analysis [J].
Yoon, Seung Bae ;
Park, Jae Myung ;
Lim, Chul-Hyun ;
Cho, Yu Kyung ;
Choi, Myung-Gyu .
HELICOBACTER, 2014, 19 (04) :243-248